Collegium Pharmaceutical (NASDAQ: COLL)
Collegium Pharmaceutical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Collegium Pharmaceutical Company Info
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
News & Analysis
Why Collegium Pharmaceutical Rose Nearly 10% on Tuesday
It's not every day that a company graduates to a slot in a high-profile stock index.
Investing $5,000 in These 2 Biotechs Could Make You Rich
These two companies aren't reinventing the wheel, but they still have the potential for tremendous growth.
3 Top Healthcare Stocks You Can Buy Now for Less Than $40
These three health-related businesses are well positioned to provide market-beating gains.
Here's the Best Healthcare Stock on Robinhood to Buy Now
This is the story of an emerging healthcare company on its way to capturing a billion-dollar market opportunity.
2 Value Stocks That Will Make You Richer in May
These are the two healthcare stocks that possess the best value for the greatest reward in May.
Should You Buy This Biotech That Makes A Lower Risk Painkiller?
A company making abuse-deterrent opioids and that's barely listed in any nation-wide opioid litigation is becoming a rising star despite the prescription overdose crisis.
Why Collegium Pharmaceutical Shares Are Sinking Today
Investors aren't happy about the drugmaker's proposed senior convertible note offering.
Here's Why Collegium Pharmaceutical Rose as Much as 20.7% Today
The speciality pharmaceutical company purchased the full rights to an important drug product.
Valuation
Earnings Transcripts
Collegium Pharmaceutical, inc (COLL) Q3 2021 Earnings Call Transcript
COLL earnings call for the period ending September 30, 2021.
Collegium Pharmaceutical, inc (COLL) Q2 2021 Earnings Call Transcript
COLL earnings call for the period ending June 30, 2021.
Collegium Pharmaceutical Inc (COLL) Q1 2021 Earnings Call Transcript
COLL earnings call for the period ending March 31, 2021.
Collegium Pharmaceutical Inc (COLL) Q4 2020 Earnings Call Transcript
COLL earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.